<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two patients who underwent autologous bone marrow transplantation for recurrent non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> relapsed at 46 and 28 days after the transplant </plain></SENT>
<SENT sid="1" pm="."><plain>Both patients had an HLA-identical sibling and were treated with high-dose chemotherapy and allogeneic marrow transplantation </plain></SENT>
<SENT sid="2" pm="."><plain>One patient is now 24 months after the allogeneic transplant without evidence of disease </plain></SENT>
<SENT sid="3" pm="."><plain>The second patient died on day 7 with interstitial <z:hpo ids='HP_0002090'>pneumonia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>We conclude that high-dose therapy and allogeneic bone marrow transplantation after failure of autologous transplantation for non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is feasible and should be considered in young patients with HLA-identical siblings </plain></SENT>
</text></document>